What do systematic reviews say?

Emixustat vs placebo

Emixustat showed no clear difference in proportion of participants losing ≥ 15 EDTRS letters at 24 months** compared with placebo (low certainty).

• Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to… 2020 · Cochrane Headline outcomes only
  RR 0.91 [0.59, 1.4]
  1 study · 498 participants
  Low